IL1B and Parkinson disease: Research revealed elevated peripheral and brain levels of interleukin-6 (IL-6), tumor necrosis factor (TNF), IL-1β, etc. in PD patients, providing robust clinical evidence for systemic inflammatory dysregulation in PD pathogenesis [20,21].